Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

A Comparison of the Effects of Exercise Methods for Adolescent Hyperkyphosis on the Sensorimotor System

2 novembre 2026 mis à jour par: Ayse Zengin Alpozgen, Istanbul University - Cerrahpasa

Comparıson Of The Effects Of Schroth And Conventıonal Exercıses On The Sensorımotor System In Adolescents Wıth Hyperkyphosıs

This study will compare two home exercise programs for adolescents aged 10-17 years with postural hyperkyphosis: kyphosis-specific Schroth exercises and traditional stretching and strengthening exercises. It will examine whether one program is more effective at improving the ability to sense and reproduce a corrected upper-back posture. The researchers expect the Schroth program to lead to greater improvement.

Aperçu de l'étude

Description détaillée

This study will compare two home-based exercise programs for adolescents aged 10-17 years with postural hyperkyphosis. Participants will follow either kyphosis-specific Schroth exercises or conventional stretching, strengthening, and stabilization exercises for eight weeks, approximately 45 minutes per session, three days a week.

The study will assess whether the programs affect participants' ability to recognize and reproduce a corrected thoracic posture. Other outcomes will include balance, spinal curvature and posture, muscle strength and endurance, flexibility, spinal pain, and participants' perceptions of their condition and overall change. Exercise participation, how accurately the exercises are performed, and any adverse events will also be recorded.

Type d'étude

Interventionnel

Inscription (Estimé)

58

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Bakırköy
      • Istanbul, Bakırköy, Turquie (Türkiye)
        • Istanbul University-Cerrahpaşa, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
        • Contact:
        • Chercheur principal:
          • Ayşe Zengin Alpözgen, Assoc. Prof.
        • Sous-enquêteur:
          • Kübra Kardeş, Asst Prof.
        • Sous-enquêteur:
          • Çisemnur Gülnaz, BSc

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

10 ans à 17 ans (Enfant)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

Aged 10 through 17 years. Thoracic kyphosis Cobb angle greater than 40° and less than 70° from T4 to T12 on a lateral radiograph.

Flexible thoracic kyphosis that decreases with active correction on clinical examination.

Able to understand the exercise instructions and perform the home program. Written informed consent from a parent or legal guardian and written assent from the adolescent.

Exclusion Criteria:

Kyphosis other than postural kyphosis, including Scheuermann disease (at least 5° of wedging in three or more consecutive vertebrae), congenital kyphosis, or other structural or rigid kyphosis.

Structural scoliosis with a Cobb angle greater than 10°. Previous spinal surgery or major trauma affecting the spine. A diagnosed neurological condition or neurological symptoms that may affect postural control.

Diagnosed vestibular pathology or a history of vestibular problems, or current vertigo, dizziness, or balance complaints.

Visual impairment that cannot be corrected with glasses or contact lenses. Acute musculoskeletal injury or pain that would prevent assessment or exercise. Participation in physiotherapy or an exercise program for kyphosis within the previous 3 months.

Previous Schroth exercise training. Current brace treatment. Cognitive impairment that would prevent adherence to the exercise program.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Schroth exercise group

This group will perform a kyphosis-specific Schroth exercise program focused on active thoracic posture correction, axial elongation, and corrective breathing. Participants will practice the exercises at home, using a mirror for visual feedback and tactile cues to monitor their posture.

Participants will perform the program at home 3 days per week for 8 weeks, with each session lasting approximately 45 minutes, including a 5-minute warm-up and a 3-minute cool-down. Three face-to-face training sessions will be provided during week 1, followed by face-to-face follow-up visits at the beginning of weeks 3 and 5. The program will have two stages. Participants who meet the prespecified progression criteria will advance to stage 2 at the week 5 follow-up.

Comparateur actif: Conventional exercise group

This group will perform a conventional exercise program including stretching, scapular retraction, back extensor and trapezius strengthening, and trunk stabilization. The program will not include Schroth-specific active posture correction, corrective breathing, or mirror-based posture feedback.

Participants will perform the program at home 3 days per week for 8 weeks, with each session lasting approximately 45 minutes, including a 5-minute warm-up and a 3-minute cool-down. Three face-to-face training sessions will be provided during week 1, followed by face-to-face follow-up visits at the beginning of weeks 3 and 5. The program will have two stages. Participants who meet the prespecified progression criteria will advance to stage 2 at the week 5 follow-up.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Thoracic Extension Absolute Repositioning Error
Délai: At baseline and at the end of Week 8

Thoracic position sense will be assessed with dual digital inclinometers placed at T1 and T12. With eyes closed, participants will reproduce a 15° thoracic extension target. The primary measure is the mean absolute difference between the target and reproduced angles across five trials, in degrees; lower values indicate smaller error. Flexion (30°) and right and left lateral flexion (20°) will also be measured as secondary directional outcomes.

At baseline and at the end of Week 8

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Balance
Délai: At baseline and at the end of Week 8

Balance will be assessed with the AI Balance system using the modified Clinical Test of Sensory Interaction on Balance (four eyes-open/eyes-closed conditions on firm and foam surfaces; three 30-second trials per condition) and the Limits of Stability test (weight shifting toward eight targets). Higher sway index values indicate greater sway; higher Limits of Stability scores indicate better performance.

At baseline and at the end of Week 8
Thoracic Curvature
Délai: At baseline and at the end of Week 8

Thoracic curvature will be measured with a Flexicurve ruler from C7 to T12. The kyphosis index will be calculated as the kyphosis apex depth divided by the curve length, multiplied by 100. The values above 13 indicate hyperkyphosis.

At baseline and at the end of Week 8
Sagittal Posture
Délai: At baseline and at the end of Week 8

Sagittal posture will be assessed from a lateral photograph using the PostureScreen Mobile application. Landmark displacement will be recorded in centimeters under standardized camera, posture, clothing, and hair conditions.

At baseline and at the end of Week 8
Muscle Strength
Délai: At baseline and at the end of Week 8

Isometric strength of the trunk flexors and extensors, upper, middle, and lower trapezius, and serratus anterior will be measured using a hand-held dynamometer and the make-test method. Three 5-second contractions will be performed for each muscle group. Mean force will be normalized to body weight and reported in N/kg.

At baseline and at the end of Week 8
Flexibility
Délai: At baseline and at the end of Week 8

Hamstring and lower-back flexibility will be measured with the sit-and-reach test; the maximum distance across three trials will be recorded in centimeters. Pectoralis minor muscle length will be measured bilaterally with a tape measure; the mean of three measurements will be analyzed.

At baseline and at the end of Week 8
Muscle Endurance
Délai: At baseline and at the end of Week 8

Scapular, trunk flexor, and trunk extensor endurance will be assessed using the isometric scapular endurance, McGill trunk flexor endurance, and Biering-Sørensen tests, respectively. The time each position is maintained without compensation will be recorded in seconds. Each test will be performed once, with at least 5 minutes of rest between tests.

At baseline and at the end of Week 8
Spinal Pain
Délai: At baseline and at the end of Week 8

Resting, activity-related, and nocturnal spinal pain during the previous week will be rated on a 0-10 cm Visual Analog Scale, where 0 indicates no pain and 10 indicates the worst possible pain.

At baseline and at the end of Week 8
Deformity Perception
Délai: At baseline and at the end of Week 8

Deformity perception will be assessed with the Turkish version of the Kyphosis-Specific Spinal Appearance Questionnaire. The 10-item questionnaire is scored from 1 to 5; the mean item score will be analyzed. Higher scores indicate a more negative perception of spinal appearance.

At baseline and at the end of Week 8
Perceived Global Change
Délai: At the end of Week 8

Overall perceived change will be assessed using the 7-point Global Rating of Change scale, from -3 (much worse) to +3 (much better), with 0 indicating no change. Scores of +2 or +3 will indicate a clinically meaningful perceived improvement.

At the end of Week 8

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

15 novembre 2026

Achèvement primaire (Estimé)

15 mai 2027

Achèvement de l'étude (Estimé)

15 juin 2027

Dates d'inscription aux études

Première soumission

2 novembre 2026

Première soumission répondant aux critères de contrôle qualité

2 novembre 2026

Première publication (Réel)

6 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

6 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner